TY - JOUR
T1 - Clinical outcomes after revision knee arthroplasty due to periprosthetic joint infection
T2 - A single-centre study of 359 knees at a high-volume centre with a minimum of one year follow-up
AU - Liukkonen, Rasmus
AU - Honkanen, Meeri
AU - Skyttä, Eerik
AU - Eskelinen, Antti
AU - Karppelin, Matti
AU - Reito, Aleksi
N1 - © 2025 The Author(s). Knee Surgery, Sports Traumatology, Arthroscopy published by John Wiley & Sons Ltd on behalf of European Society of Sports Traumatology, Knee Surgery and Arthroscopy.
PY - 2025/7/7
Y1 - 2025/7/7
N2 - PURPOSE: Decisions on the treatment of periprosthetic joint infection (PJI) are typically guided by established algorithms. However, as these algorithms often lack substantial supporting evidence, this study aimed to evaluate 1-year survival rates and compare different surgical approaches.METHODS: In this single-centre retrospective cohort study, all revisions of the knee due to PJI with at least 1 year of follow-up performed between January 2008 and September 2021 were identified. In total, 141 debridement, antibiotics, and implant retentions (DAIRs), 98 one-stage, and 120 two-stage revisions were performed. Infections were classified as early, acute hematogenous, or chronic infections. Survival was calculated using the Kaplan-Meier method and the cumulative incidence function. Predictors of outcomes were examined with Fine-Gray regression and Cox proportional hazards regression, and subdistribution hazard ratios (sdHR) and adjusted hazard ratios (aHR) with 95% confidence intervals (CIs) were calculated.RESULTS: At 1-year follow-up, 23% (CI 19%-27%) of patients had undergone a reoperation, and 4% (CI 2%-6%) had died. The risk of reoperation was largest after two-stage revision (28%, CI 20%-36%) and smallest after one-stage revision (15%, CI 9%-23%). For every infection type, the failure rates at one-year follow-up favoured one-stage revision over two-stage revision. Higher ASA-scores increased the risk of death (aHR 1.7, CI 1.1-2.5 per one-unit increase).CONCLUSION: The risk of failure after one-year follow-up is high after revision for periprosthetic joint infection. The lowest risk was observed after one-stage revision; however, this may partly reflect patient selection, as one-stage revision may not be suitable for all patients.LEVEL OF EVIDENCE: Level III, retrospective comparative study.
AB - PURPOSE: Decisions on the treatment of periprosthetic joint infection (PJI) are typically guided by established algorithms. However, as these algorithms often lack substantial supporting evidence, this study aimed to evaluate 1-year survival rates and compare different surgical approaches.METHODS: In this single-centre retrospective cohort study, all revisions of the knee due to PJI with at least 1 year of follow-up performed between January 2008 and September 2021 were identified. In total, 141 debridement, antibiotics, and implant retentions (DAIRs), 98 one-stage, and 120 two-stage revisions were performed. Infections were classified as early, acute hematogenous, or chronic infections. Survival was calculated using the Kaplan-Meier method and the cumulative incidence function. Predictors of outcomes were examined with Fine-Gray regression and Cox proportional hazards regression, and subdistribution hazard ratios (sdHR) and adjusted hazard ratios (aHR) with 95% confidence intervals (CIs) were calculated.RESULTS: At 1-year follow-up, 23% (CI 19%-27%) of patients had undergone a reoperation, and 4% (CI 2%-6%) had died. The risk of reoperation was largest after two-stage revision (28%, CI 20%-36%) and smallest after one-stage revision (15%, CI 9%-23%). For every infection type, the failure rates at one-year follow-up favoured one-stage revision over two-stage revision. Higher ASA-scores increased the risk of death (aHR 1.7, CI 1.1-2.5 per one-unit increase).CONCLUSION: The risk of failure after one-year follow-up is high after revision for periprosthetic joint infection. The lowest risk was observed after one-stage revision; however, this may partly reflect patient selection, as one-stage revision may not be suitable for all patients.LEVEL OF EVIDENCE: Level III, retrospective comparative study.
U2 - 10.1002/ksa.12762
DO - 10.1002/ksa.12762
M3 - Article
C2 - 40622081
SN - 0942-2056
JO - KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY
JF - KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY
ER -